Year: 2014
Type: review
Abstract: Cells exposed to extreme physicochemical or mechanical stimuli die in an uncontrollable manner, as a result of their immediate structural breakdown. Such an unavoidable variant of cellular demise is generally referred to as 'accidental cell death' (ACD). In most settings, however, cell death is initiated by a genetically encoded apparatus, correlating with the fact that its course can be altered by pharmacologic or genetic interventions. 'Regulated cell death' (RCD) can occur as part of physiologic programs or can be activated once adaptive responses to perturbations of the extracellular or intracellular microenvironment fail. The biochemical phenomena that accompany RCD may be harnessed to classify it into a few subtypes, which often (but not always) exhibit stereotyped morphologic features. Nonetheless, efficiently inhibiting the processes that are commonly thought to cause RCD, such as the activation of executioner caspases in the course of apoptosis, does not exert true cytoprotective effects in the mammalian system, but simply alters the kinetics of cellular demise as it shifts its morphologic and biochemical correlates. Conversely, bona fide cytoprotection can be achieved by inhibiting the transduction of lethal signals in the early phases of the process, when adaptive responses are still operational. Thus, the mechanisms that truly execute RCD may be less understood, less inhibitable and perhaps more homogeneous than previously thought. Here, the Nomenclature Committee on Cell Death formulates a set of recommendations to help scientists and researchers to discriminate between essential and accessory aspects of cell death.
Source: Cell Death and Differentiation
DOI: 10.1038/cdd.2014.137
Authors: L Galluzzi, J M Bravo-San Pedro, I Vitale, S A Aaronson, J M Abrams, D Adam, E S Alnemri, L Altucci, D Andrews, M Annicchiarico-Petruzzelli, E H Baehrecke, N G Bazan, M J Bertrand, K Bianchi, M V Blagosklonny, K Blomgren, C Borner, D E Bredesen, C Brenner, M Campanella, E Candi, F Cecconi, F K Chan, N S Chandel, E H Cheng, J E Chipuk, J A Cidlowski, A Ciechanover, T M Dawson, V L Dawson, V De Laurenzi, R De Maria, K-M Debatin, N Di Daniele, V M Dixit, B D Dynlacht, W S El-Deiry, G M Fimia, R A Flavell, S Fulda, C Garrido, M-L Gougeon, D R Green, H Gronemeyer, G Hajnoczky, J M Hardwick, M O Hengartner, H Ichijo, B Joseph, P J Jost, T Kaufmann, O Kepp, D J Klionsky, R A Knight, S Kumar, J J Lemasters, B Levine, A Linkermann, S A Lipton, R A Lockshin, C López-Otín, E Lugli, F Madeo, W Malorni, J-C Marine, S J Martin, J-C Martinou, J P Medema, P Meier, S Melino, N Mizushima, U Moll, C Muñoz-Pinedo, G Nuñez, A Oberst, T Panaretakis, J M Penninger, M E Peter, M Piacentini, P Pinton, J H Prehn, H Puthalakath, G A Rabinovich, K S Ravichandran, R Rizzuto, C M Rodrigues, D C Rubinsztein, T Rudel, Y Shi, H-U Simon, B R Stockwell, G Szabadkai, S W Tait, H L Tang, N Tavernarakis, Y Tsujimoto, T Vanden Berghe, P Vandenabeele, A Villunger, E F Wagner, H Walczak, E White, W G Wood, J Yuan, Z Zakeri, B Zhivotovsky, G Melino, G Kroemer
Institutions: Institut Gustave Roussy, Sorbonne Paris Cité, Centre de Recherche des Cordeliers, La Ligue Contre le Cancer, Université Paris Descartes, Fondation Gustave Roussy, Inserm, Instituto Nazionale Tumori Regina Elena, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, The University of Texas Southwestern Medical Center, Christian-Albrechts-Universität zu Kiel, Thomas Jefferson University, University of Campania "Luigi Vanvitelli", University of Toronto, Istituto Dermopatico dell'Immacolata, Istituti di Ricovero e Cura a Carattere Scientifico, University of Massachusetts Chan Medical School, Ghent University, VIB-UGent Center for Inflammation Research, Queen Mary University of London, Cancer Research UK, Barts Cancer Institute, Roswell Park Comprehensive Cancer Center, Karolinska University Hospital, Karolinska Institutet, University of Freiburg, Buck Institute for Research on Aging, University of California, San Francisco, Université Paris-Sud, Laboratoire d'Excellence en Recherche sur le Médicament et l'Innovation Thérapeutique, University College London, University of Rome Tor Vergata, Danish Cancer Society, Fondazione Santa Lucia, Northwestern University, Memorial Sloan Kettering Cancer Center, National Institutes of Health, National Institute of Environmental Health Sciences, Technion – Israel Institute of Technology, Rappaport Family Institute for Research in the Medical Sciences, Johns Hopkins University, Johns Hopkins Medicine, Adrienne Helis Malvin Medical Research Foundation, University of Chieti-Pescara, University Hospital Ulm, Genentech, New York University, Penn State Cancer Institute, Penn State Milton S. Hershey Medical Center, University of Salento, Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani, Yale University, Goethe University Frankfurt, Université de Bourgogne, Institut Pasteur, St. Jude Children's Research Hospital, Institut de génétique et de biologie moléculaire et cellulaire, University of Zurich, The University of Tokyo, Technical University of Munich, University of Bern, University of Michigan, Medical Research Council, University of South Australia, Centre for Cancer Biology, The University of Adelaide, Medical University of South Carolina, Howard Hughes Medical Institute, Scripps Research Institute, Salk Institute for Biological Studies, Sanford Burnham Prebys Medical Discovery Institute, University of California San Diego, St. John's University, Universidad de Oviedo, University of Graz, Istituto Superiore di Sanità, VIB-KU Leuven Center for Cancer Biology, KU Leuven, Trinity College Dublin, University of Geneva, Amsterdam UMC Location University of Amsterdam, Institute of Cancer Research, Stony Brook University, Institut d'Investigació Biomédica de Bellvitge, University of Washington, Institute of Molecular Biotechnology, Austrian Academy of Sciences, University of Ferrara, Royal College of Surgeons in Ireland, La Trobe University, Consejo Nacional de Investigaciones Científicas y Técnicas, Experimental Medicine and Biology Institute, University of Virginia, University of Padua, University of Lisbon, University of Cambridge, University of Würzburg, Soochow University, Columbia University, Cancer Research UK Scotland Institute, University of Glasgow, University of Crete, Foundation for Research and Technology Hellas, Osaka International Cancer Institute, Innsbruck Medical University, Spanish National Cancer Research Centre, Rutgers, The State University of New Jersey, Rutgers Cancer Institute, University of Minnesota, Minneapolis VA Medical Center, Harvard University, Queens College, CUNY, The Graduate Center, CUNY, City University of New York, Lomonosov Moscow State University, Assistance Publique – Hôpitaux de Paris, Hôpital Européen Georges-Pompidou
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $5,790
Funders: Wellcome Trust, Medical Research Council, Biotechnology and Biological Sciences Research Council, Japan Society for the Promotion of Science, National Institute on Alcohol Abuse and Alcoholism, National Institute on Drug Abuse, National Cancer Institute, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Neurological Disorders and Stroke, Eunice Kennedy Shriver National Institute of Child Health and Human Development
Awards: Regulation of Wnt Pathway Specificity, BCL2 Family Protein Interactions In Cellular Survival States, Liver Preservation for Transplantation, Mechanisms of I/R Injury to Hepatocytes, Drug Abuse Research Center, Modeling Parkinson's Disease with Isogenic hiPSC-Derived Dopaminergic Neurons, Survival Function of the Fadd-Caspase-8-Flip Complex, To the edge of necroptosis and back, Homeostasis Regulation via Stress Signaling and its Molecular Basis for Drug Development, Chemical genetic profiling of engineered tumor cells, Cellular Medicine at the Cambridge Institute for Medical Research., Cellular/Molecular Pathophysiology of Intellectual and Developmental Disabilities, Defining mechanisms and targets in Wnt addicted human malignancies (PQ22), Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50), Harnessing TNF-mediated cell death in cancer, p53 - Regulators and Effectors, Molecular and Genetic Control of Programmed Cell Death, Role of Autophagy in Cancer, Role of the mitochondrial Translocator Protein (mTSPO) in cell homeostasis: a molecular pathway in signalling and self-conservation mechanisms, Alternative Vacuolar Targeting Mechanisms in Yeast, Autophagy in health and disease., Tumor cell metabolism in action, VDAC in Ethanol and Aldehyde-Induced Mitochondrial Dysfunction
OpenAlex ID: W1997128330
